Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies, Inc. Breast Cancer Intrinsic Subtype Test

NCT01974856 is registered in ClinicalTrials.gov with NanoString Technologies, Inc. as lead sponsor.

NCT NCT01974856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01974856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies, Inc. Breast Cancer Intrinsic Subtype Test
Lead sponsor
NanoString Technologies, Inc.
Phase
Observational
Overall status
Completed
Start date
October 31, 2013
Completion date
June 30, 2015
Enrollment
201 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer